These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6834499)

  • 21. The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes.
    Mikel Hubanks J; Boorjian SA; Frank I; Gettman MT; Houston Thompson R; Rangel LJ; Bergstralh EJ; Jeffrey Karnes R
    Urol Oncol; 2014 Jan; 32(1):26.e1-7. PubMed ID: 23395235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.
    Eastham JA; Kattan MW; Riedel E; Begg CB; Wheeler TM; Gerigk C; Gonen M; Reuter V; Scardino PT
    J Urol; 2003 Dec; 170(6 Pt 1):2292-5. PubMed ID: 14634399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radical prostatectomy with pelvic lymphadenectomy: observations on the accuracy of staging with lymph node frozen sections.
    Fowler JE; Torgerson L; McLeod DG; Stutzman RE
    J Urol; 1981 Nov; 126(5):618-9. PubMed ID: 7299921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pelvic lymphadenectomy for stage B1 adenocarcinoma or the prostate: justified or not?
    Nicholson TC; Richie JP
    J Urol; 1977 Feb; 117(2):199-201. PubMed ID: 833968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early results following radical prostatectomy in patients with capsule invasion, seminal vesicle infiltration and micrometastases].
    Terhorst B; Friedrichs R
    Urologe A; 1990 Mar; 29(2):91-5. PubMed ID: 2330669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
    Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA
    Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The therapeutic role of pelvic lymphadenectomy in prostatic cancer.
    Morales P; Golimbu M
    Urol Clin North Am; 1980 Oct; 7(3):623-9. PubMed ID: 7456175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Locoregional staging of prostatic neoplasms by extemporaneous histological examination of pelvic lymph nodes].
    Zattoni F; Pegoraro V; Guazzieri S; Dal Bianco M
    J Urol (Paris); 1985; 91(3):155-6. PubMed ID: 4045210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A; Ohlmann CH
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraoperative frozen section assessment of pelvic lymph nodes during radical prostatectomy is of limited value.
    Song J; Li M; Zagaja GP; Taxy JB; Shalhav AL; Al-Ahmadie HA
    BJU Int; 2010 Nov; 106(10):1463-7. PubMed ID: 20477824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer.
    Abdollah F; Sun M; Thuret R; Jeldres C; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Int J Urol; 2012 Jul; 19(7):645-51. PubMed ID: 22416788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pelvic lymphadenectomy for staging localized prostatic cancer.
    Dahl DS; Wilson CS; Middleton RG; Bourne HH
    J Urol; 1974 Aug; 112(2):245-6. PubMed ID: 4858411
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinicopathologic features of unsuspected regional lymph node metastases in prostatic adenocarcinoma.
    Saltzstein SL; McLaughlin AP
    Cancer; 1977 Sep; 40(3):1212-21. PubMed ID: 902239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.
    Wang L; Hricak H; Kattan MW; Schwartz LH; Eberhardt SC; Chen HN; Scardino PT
    AJR Am J Roentgenol; 2006 Mar; 186(3):743-8. PubMed ID: 16498101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
    Karam JA; Svatek RS; Karakiewicz PI; Gallina A; Roehrborn CG; Slawin KM; Shariat SF
    Clin Cancer Res; 2008 Mar; 14(5):1418-22. PubMed ID: 18316564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy and cost of intraoperative lymph node frozen sections at radical prostatectomy.
    Young MP; Kirby RS; O'Donoghue EP; Parkinson MC
    J Clin Pathol; 1999 Dec; 52(12):925-7. PubMed ID: 10711259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lesion size on prostate magnetic resonance imaging predicts adverse radical prostatectomy pathology.
    Tonttila PP; Kuisma M; Pääkkö E; Hirvikoski P; Vaarala MH
    Scand J Urol; 2018 Apr; 52(2):111-115. PubMed ID: 29291666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of and indications for pelvic lymph node dissection in the staging of prostate cancer.
    Middleton RG
    NCI Monogr; 1988; (7):41-3. PubMed ID: 3173502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.